Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022024517> ?p ?o ?g. }
- W2022024517 endingPage "695" @default.
- W2022024517 startingPage "689" @default.
- W2022024517 abstract "PURPOSE To report the initial clinical experience with the use of n-butyl cyanoacrylate (NBCA) for embolization of acute arterial hemorrhage from varied etiologies and at varied anatomic sites. MATERIALS AND METHODS Sixteen patients who demonstrated active extravasation of contrast material and/or arterial abnormality underwent NBCA embolization. Sites of embolization included the gastrointestinal tract, kidney, liver, uterus, adrenal gland, extremity, and chest wall. Standard coil or particulate embolization had previously failed in 10 patients. NBCA was used as the initial embolic agent in the remaining six patients. After treatment, serial hematocrit levels, transfusion requirements, and clinical signs and symptoms were monitored for stabilization. Patients were evaluated for signs and symptoms of end-organ damage. RESULTS NBCA embolization was successful in 12 of 16 patients (75%), who exhibited complete cessation of bleeding. In four patients (25%), NBCA embolization was of no benefit. Embolization failed in two of 16 patients (12.5%), who showed evidence of recurrent bleeding after use of NBCA. The remaining two patients (12.5%) died within 24 hours of the procedure. None of the 16 patients developed clinical signs of end-organ damage or iatrogenic ischemia attributable to NBCA. CONCLUSIONS In this initial limited series, NBCA embolization was shown to be a feasible and effective method to control acute arterial hemorrhage. NBCA embolization was able to stop arterial bleeding even when previous coil or particulate embolization had failed. To report the initial clinical experience with the use of n-butyl cyanoacrylate (NBCA) for embolization of acute arterial hemorrhage from varied etiologies and at varied anatomic sites. Sixteen patients who demonstrated active extravasation of contrast material and/or arterial abnormality underwent NBCA embolization. Sites of embolization included the gastrointestinal tract, kidney, liver, uterus, adrenal gland, extremity, and chest wall. Standard coil or particulate embolization had previously failed in 10 patients. NBCA was used as the initial embolic agent in the remaining six patients. After treatment, serial hematocrit levels, transfusion requirements, and clinical signs and symptoms were monitored for stabilization. Patients were evaluated for signs and symptoms of end-organ damage. NBCA embolization was successful in 12 of 16 patients (75%), who exhibited complete cessation of bleeding. In four patients (25%), NBCA embolization was of no benefit. Embolization failed in two of 16 patients (12.5%), who showed evidence of recurrent bleeding after use of NBCA. The remaining two patients (12.5%) died within 24 hours of the procedure. None of the 16 patients developed clinical signs of end-organ damage or iatrogenic ischemia attributable to NBCA. In this initial limited series, NBCA embolization was shown to be a feasible and effective method to control acute arterial hemorrhage. NBCA embolization was able to stop arterial bleeding even when previous coil or particulate embolization had failed." @default.
- W2022024517 created "2016-06-24" @default.
- W2022024517 creator A5018768110 @default.
- W2022024517 creator A5026982655 @default.
- W2022024517 creator A5049750518 @default.
- W2022024517 creator A5058858234 @default.
- W2022024517 creator A5063398332 @default.
- W2022024517 date "2004-07-01" @default.
- W2022024517 modified "2023-10-16" @default.
- W2022024517 title "N-Butyl Cyanoacrylate Embolization for Control of Acute Arterial Hemorrhage" @default.
- W2022024517 cites W1503298002 @default.
- W2022024517 cites W1519119771 @default.
- W2022024517 cites W1966615698 @default.
- W2022024517 cites W1979417328 @default.
- W2022024517 cites W1982208056 @default.
- W2022024517 cites W1985651239 @default.
- W2022024517 cites W1992289774 @default.
- W2022024517 cites W2002324532 @default.
- W2022024517 cites W2008176758 @default.
- W2022024517 cites W2026105044 @default.
- W2022024517 cites W2029381157 @default.
- W2022024517 cites W2036482788 @default.
- W2022024517 cites W2037725156 @default.
- W2022024517 cites W2042625651 @default.
- W2022024517 cites W2046938419 @default.
- W2022024517 cites W2052414795 @default.
- W2022024517 cites W2059388713 @default.
- W2022024517 cites W2059749940 @default.
- W2022024517 cites W2074258773 @default.
- W2022024517 cites W2092584306 @default.
- W2022024517 cites W4230463730 @default.
- W2022024517 cites W4236323445 @default.
- W2022024517 doi "https://doi.org/10.1097/01.rvi.0000133505.84588.8c" @default.
- W2022024517 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15231881" @default.
- W2022024517 hasPublicationYear "2004" @default.
- W2022024517 type Work @default.
- W2022024517 sameAs 2022024517 @default.
- W2022024517 citedByCount "131" @default.
- W2022024517 countsByYear W20220245172012 @default.
- W2022024517 countsByYear W20220245172013 @default.
- W2022024517 countsByYear W20220245172014 @default.
- W2022024517 countsByYear W20220245172015 @default.
- W2022024517 countsByYear W20220245172016 @default.
- W2022024517 countsByYear W20220245172017 @default.
- W2022024517 countsByYear W20220245172018 @default.
- W2022024517 countsByYear W20220245172019 @default.
- W2022024517 countsByYear W20220245172020 @default.
- W2022024517 countsByYear W20220245172021 @default.
- W2022024517 countsByYear W20220245172022 @default.
- W2022024517 countsByYear W20220245172023 @default.
- W2022024517 crossrefType "journal-article" @default.
- W2022024517 hasAuthorship W2022024517A5018768110 @default.
- W2022024517 hasAuthorship W2022024517A5026982655 @default.
- W2022024517 hasAuthorship W2022024517A5049750518 @default.
- W2022024517 hasAuthorship W2022024517A5058858234 @default.
- W2022024517 hasAuthorship W2022024517A5063398332 @default.
- W2022024517 hasConcept C126322002 @default.
- W2022024517 hasConcept C126838900 @default.
- W2022024517 hasConcept C137627325 @default.
- W2022024517 hasConcept C141071460 @default.
- W2022024517 hasConcept C178790620 @default.
- W2022024517 hasConcept C185592680 @default.
- W2022024517 hasConcept C2776035437 @default.
- W2022024517 hasConcept C2778171257 @default.
- W2022024517 hasConcept C2779227376 @default.
- W2022024517 hasConcept C2911105935 @default.
- W2022024517 hasConcept C68928338 @default.
- W2022024517 hasConcept C71924100 @default.
- W2022024517 hasConceptScore W2022024517C126322002 @default.
- W2022024517 hasConceptScore W2022024517C126838900 @default.
- W2022024517 hasConceptScore W2022024517C137627325 @default.
- W2022024517 hasConceptScore W2022024517C141071460 @default.
- W2022024517 hasConceptScore W2022024517C178790620 @default.
- W2022024517 hasConceptScore W2022024517C185592680 @default.
- W2022024517 hasConceptScore W2022024517C2776035437 @default.
- W2022024517 hasConceptScore W2022024517C2778171257 @default.
- W2022024517 hasConceptScore W2022024517C2779227376 @default.
- W2022024517 hasConceptScore W2022024517C2911105935 @default.
- W2022024517 hasConceptScore W2022024517C68928338 @default.
- W2022024517 hasConceptScore W2022024517C71924100 @default.
- W2022024517 hasIssue "7" @default.
- W2022024517 hasLocation W20220245171 @default.
- W2022024517 hasLocation W20220245172 @default.
- W2022024517 hasOpenAccess W2022024517 @default.
- W2022024517 hasPrimaryLocation W20220245171 @default.
- W2022024517 hasRelatedWork W1964931687 @default.
- W2022024517 hasRelatedWork W2024983167 @default.
- W2022024517 hasRelatedWork W2065174691 @default.
- W2022024517 hasRelatedWork W2115286259 @default.
- W2022024517 hasRelatedWork W2295987156 @default.
- W2022024517 hasRelatedWork W2367189954 @default.
- W2022024517 hasRelatedWork W2375311395 @default.
- W2022024517 hasRelatedWork W2404953125 @default.
- W2022024517 hasRelatedWork W2614854921 @default.
- W2022024517 hasRelatedWork W2907441285 @default.
- W2022024517 hasVolume "15" @default.
- W2022024517 isParatext "false" @default.
- W2022024517 isRetracted "false" @default.